Who is sponsoring NCT01011634?

NCT01011634 is sponsored by University of California, San Francisco.

What condition does NCT01011634 study?

NCT01011634 studies Undesired Intrauterine Pregnancy, First Trimester Pregnancy.

What drugs are being tested in NCT01011634?

Interventions: Intravenous moderate sedation versus oral medication.

What is the status of NCT01011634?

NCT01011634 is currently TERMINATED.

Last reviewed 2013-05-14 · How we verify

A Double Blinded, Placebo-controlled Randomized Control Trial Comparing Intravenous Moderate Sedation and Oral/Sublingual Analgesia/Anxiolysis for First Trimester Surgical Abortions

NCT01011634 Phase 4 TERMINATED Results posted

In the United States, the majority of first-trimester surgical abortions are performed in outpatient clinics that utilize a wide variety of oral and intravenous regimens for pain control. The specific aim of this study is to evaluate the equivalency of intravenous moderate sedation (fentanyl 100 mcg and midazolam 2 mg) versus oral analgesia/anxiolysis (lorazepam 2 mg sublingual, hydrocodone/acetaminophen 5/500 mg, and ibuprofen 800 mg) for first-trimester surgical abortions. The investigators hypothesize that oral moderate sedation and intravenous moderate sedation will be equivalent in controlling pain as measured by a difference of +/- 10 on a 100-point (range 0-100) visual analog pain scale.

Details

Lead sponsor	University of California, San Francisco
Phase	Phase 4
Status	TERMINATED
Enrolment	18
Start date	2007-05
Completion	2008-11

Conditions

Undesired Intrauterine Pregnancy
First Trimester Pregnancy

Interventions

Intravenous moderate sedation versus oral medication

Primary outcomes

Pain Score Within 5 Mins After Procedure — within 5 mins after procedure

Countries

United States